Serum cystatin C measurement has been previously shown by ourselves and others to be a better indicator of changes in glomerular ®ltration rate (GFR) than serum creatinine. However, the available literature on reference values for cystatin C concentration remains surprisingly sparse; we thus set out to determine an adult reference range. Blood was taken from 309 healthy blood donors and creatinine and cystatin C concentrations were measured using commercially available automatedmethodologies.In addition, predicted creatinine clearances were calculated using the Cockcroft and Gault formula. The 95% reference intervals for creatinine, predicted creatinineclearanceand cystatin C for all blood donors, regardless of gender, were 68±118 mmol/L, 58±120 ml/min/1´73 m 2 and 0´51±0´98 mg/L, respectively. For women, the intervals were 68±98 mmol/L, 60±119 ml/min/1´73 m 2 and 0´49±0´94 mg/ L; for men, they were 78±123 mmol/L, 57±122 ml/min/1´73 m 2 and 0´56±0´98 mg/L. The mean 95% reference interval for cystatin C in all donors under 50 years of age was 0´53±0´92 mg/L; for those over 50 years of age it was 0´58±1´02 mg/L. The small difference between male and female ranges meant that a single reference range for cystatin C could be established for all adults under 50 years of age without adjustment for body surface area. Serum cystatin C measurement offers a simpler and more sensitive screening test than serum creatinine for early changes in GFR. FIGURE 1. Box-and-whisker plots of (a) JaffeÂ creatinine, (b) JaffeÂ creatinine/body surface area and (c) predicted creatinine clearance separated by gender (2´5, 25, 50, 75 and 97´5 percentiles and outliers are shown).
INTRODUCTION
In recent years it has been suggested that cystatin C measurement in serum re¯ects changes in glomerular ®ltration rate (GFR) better than serum creatinine does. 1±3 Cystatin C is a non-glycosylated, low-molecular-weight (13 000) basic protein (pI=9´2) that is a member of the cystatin superfamily of cysteine protease inhibitors. 4±6 It consists of 120 amino acids and is produced by all nucleated cells. Structural analysis of the cystatin C gene and its promoter has shown that the gene is of the house-keeping type, which is compatible with a stable production rate by most cells, even under in¯ammatory stimuli. 1, 2, 7 A number of automated methods have been developed to measure cystatin C, including a commercially available particleenhanced turbidimetric immunoassay (PETIA), 8 an in-house latex PETIA 9 and a latex particleenhanced nephelometric immunoassay (PE-NIA). 10 The majority of these methods use technologies that are applicable to the same instruments with which serum creatinine is analysed.
As cystatin C is a new marker for GFR, there are limited data available on its reference range and whether or not there are any gender-or agerelated differences. The ranges that do exist vary enormously (see Table 1 ), but this is probably due to the different calibrators and/or antibodies used in the different methods. 8,11±18 Previously, it had been suggested that cystatin C concentrations were independent of gender, but Pergande and Jung reported that serum cystatin C concentrations were lower in women than in men. 16 As mentioned in a recent editorial, 19 in order to con®rm the utility of cystatin C a comprehensive reference range for cystatin C needs to be established and compared with the sex-and age-related differences that are known to exist with creatinine concentrations. We have investigated the reference ranges, according to International Federation of Clinical Chemistry criteria, for serum creatinine and predicted creatinine clearance (which is now recommended by a number of authoritative articles 20±22 ) using a kinetic JaffeÂ method, and for cystatin C using a PENIA method.
MATERIALS AND METHODS

Creatinine
Creatinine was measured using a JaffeÂ method 23 and performed on a Monarch 2000 [Instrumentation Laboratory (IL), Warrington, UK]. The method was calibrated using ReferrIL [ A Calibrator (cat. no. 35261; IL, Warrington, UK), which is an aqueous solution for creatinine calibration on the Monarch. Nycomed (Oslo, Norway) low and medium concentrations of control materials were used for quality assurance.
Cystatin C
Serum cystatin C was measured using a latex PENIA method on the BNA (Dade Behring GmbH, Marburg, Germany). 10 The method was calibrated using a standard supplied by Dade Behring, made with cystatin C puri®ed from human urine and assigned the value of 1´53 mg/L by amino acid analysis. Pooled serum samples containing low and medium concentrations of cystatin C were used as quality control materials.
Subjects
Serum samples were collected from 309 healthy blood donors during ®ve blood-donation sessions (10´00 a.m.±12´00 p.m. and 2´00±4´30 p.m.) over a 1-month period. The samples were collected in the non-fasting state. Donors all ful®lled the following requirements: to be ®t and well; between 18 and 60 years of age (three regular, ®t donors over 60 years of age were also included); weight more than 50 kg; no serious illness, vaccination or immunization in the previous 3 weeks; no exposure to hepatitis, human immunode®ciency virus (HIV) or malaria; no treatment with human growth hormone, or attendance at a sexually transmitted diseases clinic or overseas travel in the last year. They also had to state when they had last visited a doctor or dentist and why, whether they were attending hospital and for what reason and, ®nally, whether they were on any medication. Gender, age, weight and height were obtained by questioning every individual who consented to give extra blood for this study. Each subject was seated for 10±15 min before, and lying down for 15±20 min during, the blood donation. Blood was collected into a 10-ml plain sample tube via an open-ended cannulated line; the serum was separated by centrifugation (10 min, 3000 g) and frozen at 2 20 Ê C within 8 h of collection. All samples were negative for hepatitis B, hepatitis C, HIV and syphilis as assessed by the Blood Transfusion Service. A total of 340 subjects were entered into the study but 31 were subsequently excluded (17 refused to estimate their weight and 14 failed to supply a blood sample). Of the 309 subjects, 155 were female and 154 were male, with an age range of 19±67 years (mean age 36 years; mean age for women 34 years; mean age for men 38 years). Mean (range) weight was 72´7 (50´8±136´5) kg, with mean values for men and women of 80´4 and 64´8 kg, respectively. Mean (range) height was 1´72 (1´52±1´96) m, with mean values for men and women of 1´79 and 1´72 m, respectively. Ninety-®ve per cent of subjects (294/309) were Caucasian, with only 2% (6/309), 2% (7/309) and 0´6% (2/309) from Afro-Caribbean, Asian and Oriental ethnic groups, respectively. There were 78 smokers (25%) and 22 vegetarians (7%) among the cohort.
Statistical analysis
All statistical analyses were performed using the Astute statistical package (Diagnostic Development Unit, University of Leeds, UK). Tests of normality were performed using the Kolmogorov ±Smirnov and Anderson±Darling tests taking P< 0´001 as a signi®cant result. 24, 25 Results were arranged by sex and by age groups within each sex. All creatinine and cystatin C values were recalculated to correct for body weight using the formula:
Predicted creatinine clearance was calculated using the formula:
where k=0´85 in women and 1´00 in men. 26 Reference intervals were calculated using the mean6 2 SD of the log-transformed serum cystatin C and creatinine values and the mean6 2 SD of the untransformed, calculated creatinine clearance values.
RESULTS
Quality control
Low and medium concentrations of quality control material were measured and betweenrun precision was found to be <5% for all the controls (see Table 2 ).
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Normality
Neither cystatin C nor creatinine values were normally distributed even after correction for BSA, but became normally distributed after log transformation. Predicted creatinine clearance showed Gaussian distribution. Parametric unpaired Student's t-tests were used for most subsequent analyses.
In¯uence of gender
The kinetic creatinine measurements showed that the female donors had mean creatinine values 16´4 mmol/L (17%) lower than the male donors' results (P< 0´0001), with a slightly skewed distribution to the higher concentrations. Even after correction for BSA, creatinine percentiles still exhibited differences of at least 4% between men and women: the values for women rose by 2%, but values for men decreased a signi®cant 15% (P< 0´0001). However, the predicted creatinine clearances displayed no such gender difference. The PENIA cystatin C values revealed that the mean value for women was 0´06 mg/L (8´1%) lower than the value for men (P< 0´0001), with cystatin C percentiles con®rming that the differences between men and women were smaller than those for creatinine. The cystatin C corrected values for women were 1´5% (0´01±0´02 mg/L) higher than the uncorrected values. In marked contrast, the corrected results for the men were signi®cantly lower by 0´07±0´09 mg/L (14%) than the uncorrected values (P< 0´0001), with each of the corrected values being lower than their respective values in women. The female/male differences both before and after correction for BSA are more easily seen from box-and-whisker plots (see Figs 1 and 2) .
In¯uence of age
Subjects, grouped into 10-year cohorts, were compared for differences in serum cystatin C, creatinine and predicted creatinine clearance values across the age groups (Fig. 3 ). Mean serum cystatin C values of all subjects rose signi®cantly between ages 19±29 and 30±39 years, from 0´68 to 0´72 mg/L (P< 0´05). This rise between the two age groups was reduced, and signi®cance removed, on gender separation. Values for the 30±39-and 40±49-year age groups were very similar; however, the mean values for the 550-year-old subjects were signi®cantly higher (P< 0´01). With gender separation, only the values for women remained signi®cantly different (P< 0´05) between 40±49-and 550year-old subjects. Comparison between the uncorrected and corrected values for BSA, using the paired t-test, showed that the values for women were not signi®cantly different, except for the 19±29-year-olds (P< 0´01), but the values for men were highly signi®cant (P< 0´0001) for all age groups. Overall, cystatin C concentrations were shown to be slightly lower in the youngest group, followed by constant levels until 40±49 years, after which the levels rose; the mean difference between 19±49 and 550 years was 0´07 mg/L (P< 0´0001). This difference persisted to some degree after gender separation and BSA correction. For 19±49year-old versus 550-year-old women there were signi®cant differences (P< 0´001) between both uncorrected and corrected values. For 19±49year-old versus 550-year-old men there was a signi®cant difference at the P< 0´05 level for uncorrected values, but correction for BSA removed the signi®cance (P=0´0636). The mean serum creatinine value for all 19± 29-year-olds (84´7 mmol/L) was signi®cantly lower (P< 0´001) than that for 30±39-year-olds (91´4 mmol/L). This signi®cance was removed after correction for BSA and gender separation. Serum creatinine levels remained constant throughout the adult age range after 19±29 years, with no signi®cant difference between 19±
49-year-olds and > 50-year-olds, even after correction for BSA and gender separation. Meanwhile, the predicted creatinine clearance showed a statistically signi®cant decrease with advancing age. On average, there was an 11% decrease per decade in values for both men and women.
Reference intervals
For each method, a reference interval has been established with separate values for men and women (see Table 3 ). The creatinine reference intervals show that there are noticeable differences between the sexes, con®rming the need for separate ranges. On the other hand, the ranges established by the cystatin C method show minimal differences between the sexes, allowing a single adult range to be used. Also shown are age-related reference intervals for each method for 19±49-and 550-year age groups. For cystatin C, the older age group has a higher mean and upper limit than the younger group, whereas for creatinine there are no differences between the age groups. The 19±49-year group showed a 21% higher mean predicted creatinine clearance than did the > 50-year group.
DISCUSSION
Cystatin C has been shown to be a good indicator of GFR and, with the introduction of rapid, sensitive and precise immunoassays, it is now possible to use cystatin C as a marker of GFR for diagnostic purposes. This study has addressed age-and sex-related differences, and established reference ranges for serum cystatin C and creatinine concentrations and predicted creatinine clearance.
Comparison of the reference ranges shown in Table 3 indicates that, whereas creatinine ranges are visibly different between men and women, the ranges for cystatin C are strikingly similar. The creatinine ranges show the well-established gender differences, with the range for women being 17% lower than that for men. The breadth of the range for women is , 35 mmol/L and , 47 mmol/L for men. The ranges and intervals compare well with other groups despite the differences in methodology and calibrators used. The reference range quoted by the manufacturer is somewhat different: IL does not give separate ranges for men and women but an overall range of 53±97 mmol/L (data from the manufacturer's method insert sheet).
Most cystatin C studies seem to combine both sets of gender values to give a single reference range, suggesting that the difference is insignificant. Norlund et al. claim that there is no sex difference in their study of 242 subjects; 17 for men, the mean value was 1´08 mg/L and 1´03 mg/L for women. Our study of 309 subjects does show a signi®cant difference between values for men (mean 0´74 mg/L) and women (mean 0´68 mg/L), but the range for the distributions is the same (, 0´42 mg/L) and therefore separate ranges are not necessary. A similar gender difference (0´05 mg/L) was reported by Norlund et al., but it did not reach statistical signi®cance, presumably due to slight population differences. In contrast, Pergande and Jung found that women had signi®cantly (17%) lower cystatin C concentrations (1´786 0´26) than age-matched men (2´146 0´31). 16 However, their study was smaller (33 women and 33 men) and, although we used a similar protein standard urine concentrate from Dade Behring, albeit with a different assignment method, we have not produced the same ®ndings as Pergande and Jung. The cystatin C range (0´51±0´98 mg/L) in this study is also different from those found by Kyhse-Andersen (0´61±1´21 mg/L), 8 Norlund (0´70±1´21 mg/L) 17 and Erlandsen (0´54±1´21 mg/L) (n=270); 18 these three groups used the Dakopatts method. The ELISA, Dakopatts and Dade Behring assays use different antibodies, calibrants and technologies and therefore give different reference ranges. This new marker requires an internationally agreed reference preparation in order to allow direct comparison of methods and reference ranges. The calculation of BSA requires weight and height values. These parameters were reported by the donors themselves and were not accurately measured due to the constraints imposed by the blood donor service. Although it can be argued that correction for BSA is unnecessary for cystatin C determination as there have been no reported dependencies on muscle mass, it seemed important to verify any relationship in a large-scale study such as this. There is also some dispute as to whether correction for BSA is necessary for creatinine and GFR measurement as it has been suggested that the uncorrected values more accurately re¯ect the renal function of the individual, with larger individuals simply having larger kidneys. After correction for BSA, the difference in mean serum creatinine was reduced from 16´4 mmol/L (17%) to 4 mmol/L (4%), with men still showing higher values.
Although the values for women rose on average by 2%, the values for men decreased by a signi®cant 15%. Doolan et al. showed that the sex difference was removed completely by correcting for lean body weight, but was not completely removed by correcting for body surface area. 27 In`correcting' cystatin C values for BSA, the values for women rose by 0´01 mg/ L (1´5%) whereas the values for men decreased by 0´09 mg/L (14%). The BSA corrected data are normalized to 1´73 m 2 (BSA of average 70-kg man). This results in a mean BSA/1´73 m 2 ratio of 0´99 for women and 1´15 for men. Therefore, both the creatinine and cystatin C values for women are scarcely changed whereas those for men are reduced by 14±15%. The issue of gender and BSA is complex; the signi®cance of the change is unclear and is an area of active investigation.
Renal function has been shown to decline with increasing age, with kidney size and volume decreasing after the fourth decade. 28 measurements, GFR declined after 50 years of age, decreasing by 12 mL/min per decade. 29 In this study, serum creatinine values did not seem to rise after 30 years of age even when corrected for BSA; only between 19±29 and 30±39 years was there a noticeable elevation of creatinine which was removed after correction. When the values are separated by gender the trend remains, with both sexes having negligible change in creatinine levels with increasing age. We have shown that there is no signi®cant difference between 19±49-and 550-year-olds for either sex. This contrasts with the study by Whitehead et al., who showed that both sexes had increased creatinine values with age, an effect that was more marked in men. 30 The authors suggested that many older subjects of either sex had creatinine values as low as the younger ones and that a deterioration in renal function was therefore not inevitable. The cystatin C values obtained showed that there was no statistical difference in values between 19 and 49 years of age, but the ®nding of levels rising signi®cantly after 49 years of age does con®rm the work of Norlund et al. 17 Comparing these age groups with subjects > 50 years revealed highly signi®cant differences (P< 0´0001), and correcting for BSA reduced the signi®cance to P< 0´001. Separation by gender revealed that the values for women remained highly signi®cant (P< 0´001) between 19±49 and 550 years and remained so after BSA correction, with values increasing by 0´01 mg/L (1´5%). On the other hand, the values for men were less signi®cantly different between 19±49 and > 50 years (P< 0´05), with values decreasing 0´09 mg/L (14%) after correction to non-sig-ni®cance (P=0´0552). Thus, although GFR has been shown to decrease steadily with increasing age, 31±33 serum creatinine concentrations remain constant and those of cystatin C show a signi®cant increase from the ®fth decade onwards. The failure of creatinine to rise with increasing age is probably due to a fall in the rate of creatinine production, subsequent to the fall in muscle mass that occurs with age. 28 Using serum creatinine values, age and BSA, we calculated creatinine clearance (using the Cockcroft and Gault equation). 26 This formula and derivations of it are currently recommended as the best screening test for GFR in large-scale epidemiological studies. 20±22 Predicted creatinine clearance decreased with increasing age in both men and women, falling to approximately onethird of the early adult value above 50 years of age (see Fig. 3c ). Creatinine clearance decreases after the age of 30 years, when renal function is starting to decline. The results are very similar to the actual measurements of Rowe et al. and to the calculated values of Goetz et al. 31, 34 Calculated creatinine clearance seems to be a better estimate of renal function than measured creatinine clearance and avoids having to collect urine samples as suggested recently by Toto et al. 35 This applies only to subjects whose creatinine distribution is in steady state, otherwise there is a divergence between the calculated clearance and the true clearance. 26 In conclusion, we have established a single adult reference range for cystatin C, which shows no clinically signi®cant differences between the sexes, unlike creatinine, which reveals two distinct ranges. We have shown that cystatin C levels do rise signi®cantly after the age of 50 years (n=51), even after correcting for BSA, while remaining constant between 19 and 49 years (n=258), re¯ecting the changes in GFR as renal function declines with age. Creatinine was again shown to be insensitive to this change in renal function even when corrected for BSA. The predicted creatinine clearance exhibited the largest changes in GFR across the ages but is often impractical for clinical use. To calculate creatinine clearance requires height, weight and creatinine measurements as well as the age of the individual, information that is dif®cult to obtain. This leaves serum cystatin C measurement as the simplest and most practical marker of GFR available.
